CanSino Biologics Inc. (HKG:6185)

CanSino Biologics Statistics

Total Valuation

HKG:6185 has a market cap or net worth of HKD 16.51 billion. The enterprise value is 14.99 billion.

Market Cap	16.51B
Enterprise Value	14.99B

Important Dates

The next estimated earnings date is Tuesday, October 28, 2025.

Earnings Date	Oct 28, 2025
Ex-Dividend Date	n/a

Share Statistics

HKG:6185 has 247.04 million shares outstanding. The number of shares has increased by 4.65% in one year.

Current Share Class	132.67M
Shares Outstanding	247.04M
Shares Change (YoY)	+4.65%
Shares Change (QoQ)	+33.61%
Owned by Insiders (%)	31.39%
Owned by Institutions (%)	6.83%
Float	159.11M

Valuation Ratios

PE Ratio	n/a
Forward PE	106.25
PS Ratio	16.28
PB Ratio	3.07
P/TBV Ratio	3.20
P/FCF Ratio	n/a
P/OCF Ratio	258.71
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-81.93
EV / Sales	14.79
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-50.53

Financial Position

The company has a current ratio of 2.57, with a Debt / Equity ratio of 0.39.

Current Ratio	2.57
Quick Ratio	2.32
Debt / Equity	0.39
Debt / EBITDA	n/a
Debt / FCF	-6.98
Interest Coverage	-4.73

Financial Efficiency

Return on equity (ROE) is -3.35% and return on invested capital (ROIC) is -2.21%.

Return on Equity (ROE)	-3.35%
Return on Assets (ROA)	-1.96%
Return on Invested Capital (ROIC)	-2.21%
Return on Capital Employed (ROCE)	-4.13%
Revenue Per Employee	909,288
Profits Per Employee	-164,117
Employee Count	1,105
Asset Turnover	0.12
Inventory Turnover	0.67

Taxes

Income Tax	-4.73M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +105.39% in the last 52 weeks. The beta is 1.26, so HKG:6185's price volatility has been higher than the market average.

Beta (5Y)	1.26
52-Week Price Change	+105.39%
50-Day Moving Average	49.37
200-Day Moving Average	37.06
Relative Strength Index (RSI)	48.01
Average Volume (20 Days)	1,561,953

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:6185 had revenue of HKD 1.01 billion and -182.99 million in losses. Loss per share was -0.71.

Revenue	1.01B
Gross Profit	755.74M
Operating Income	-272.37M
Pretax Income	-187.72M
Net Income	-182.99M
EBITDA	-99.80M
EBIT	-272.37M
Loss Per Share	-0.71

Balance Sheet

The company has 3.59 billion in cash and 2.07 billion in debt, giving a net cash position of 1.52 billion or 6.14 per share.

Cash & Cash Equivalents	3.59B
Total Debt	2.07B
Net Cash	1.52B
Net Cash Per Share	6.14
Equity (Book Value)	5.37B
Book Value Per Share	17.42
Working Capital	2.90B

Cash Flow

In the last 12 months, operating cash flow was 63.81 million and capital expenditures -360.49 million, giving a free cash flow of -296.68 million.

Operating Cash Flow	63.81M
Capital Expenditures	-360.49M
Free Cash Flow	-296.68M
FCF Per Share	-1.20

Margins

Gross margin is 74.54%, with operating and profit margins of -26.87% and -18.05%.

Gross Margin	74.54%
Operating Margin	-26.87%
Pretax Margin	-18.52%
Profit Margin	-18.05%
EBITDA Margin	-9.84%
EBIT Margin	-26.87%
FCF Margin	n/a

Dividends & Yields

HKG:6185 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.65%
Shareholder Yield	n/a
Earnings Yield	-1.11%
FCF Yield	-1.80%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:6185 has an Altman Z-Score of 2.18 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.18
Piotroski F-Score	6